Catalyst Wire Dossier Catalyst Wire Dossier

Gevokizumab

gevokizumab · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Gevokizumab, covering 2014-03-04 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers [Phase 1]

See pricing